The Sodium Valproate Inquiry in Ireland officially commenced on 22 July 2025, marking a crucial investigation into the historical use of this epilepsy drug and its devastating effects on children exposed in the womb. This comprehensive inquiry, chaired by Barrister Bríd O’Flaherty BL, will examine decades of prescribing practices, regulatory oversight, and the adequacy of patient warnings regarding Sodium Valproate’s risks to unborn children.